Spectral Medical Inc. (TSE:EDT – Get Free Report) shares reached a new 52-week high on Wednesday . The stock traded as high as C$0.85 and last traded at C$0.84, with a volume of 196600 shares. The stock had previously closed at C$0.78.
Spectral Medical Price Performance
The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03. The business’s 50 day moving average is C$0.71 and its two-hundred day moving average is C$0.60. The firm has a market cap of C$230.63 million, a P/E ratio of -11.71 and a beta of 0.96.
About Spectral Medical
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Further Reading
- Five stocks we like better than Spectral Medical
- How to Buy Cheap Stocks Step by Step
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- What Are Dividend Contenders? Investing in Dividend Contenders
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
